COST-EFFECTIVENESS OF PEMBROLIZUMAB (KEYTRUDA (R)) PLUS PLATINUM-PEMETREXED FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN FRANCE-MedSci.cn

COST-EFFECTIVENESS OF PEMBROLIZUMAB (KEYTRUDA (R)) PLUS PLATINUM-PEMETREXED FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN FRANCE

Chouaid, C; Bensimon, L; Millier, A; Clay, E; Insinga, R; Arunachalam, A; Khandelwal, A; Bachelot, LL; Levy, P

VALUE IN HEALTH, 2019; 22 (): S458

科室
- - 订阅+
  - 更多科室
工具
服务